Unleashing the power of Exosomes

Started in early 2015, ExoCan is a fresh new Indian start-up aimed at building interconnected technology platforms for analyzing and using Exosomes in cancer diagnosis


Dr Aman Sharma, founder & director, ExoCan

While pursuing his PhD at National Centre for Cell Sciences (NCCS), Dr Aman Sharma (32) worked on brain tumors and his attention drew towards cancer patients who were in great physical, emotional and economical agony.

He then visited a cancer hospital in Western Rajasthan and found that the lab was not researching enough on patients with cancer.

That visit sparked a fiery flame within Dr Sharma, who then decided to pursue translational research, and ended up receiving the Biotechnology Ignition Grant (BIG) worth Rs 49 lakh from BIRAC (Biotechnology Industry Research Assistance Council) in 2015 to set up his own start-up venture - ExoCan.

ExoCan is involved in developing unique Oncotechnology platforms for applications in cancer diagnosis, imaging and chemotherapy. It aims to develop technologies at lower costs with greater accessibility and clinically manage cancers for better survival outcomes.

As a plan of action, Dr Sharma secured seed funding and developed the proof-of-concept with active association with R&D institutions in India and abroad, and has so far signed MoUs with two national level research institutions.


Previous 1 3 4 5 6 7 8 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email